The challenge

Enzyme’s Vault-as-a-Service offering empowers projects to build and manage customized tokenized strategies tailored to their specific needs. These strategies can be designed as closed systems for internal capital deployment or open vaults accessible to external depositors with clearly defined objectives.

Stader Labs leveraged Enzyme.Blue to launch its ETHx Hyperloop yield product. This vault was designed to provide Stader’s community—and yield-seeking investors more broadly—with seamless access to an automated loop strategy. In the background, the vault executes a looping strategy across Aave, repeatedly borrowing and lending to generate and reinvest yield, all without requiring user intervention.

On the distribution side of the ecosystem, crypto platforms and exchanges are constantly seeking to enhance their offerings with innovative financial products. One such example is SwissBorg — a globally recognized crypto investment platform that provides intuitive, user-friendly access to digital asset strategies and yield-generating products.

‍

The solution

A long-term and trusted partner of Enzyme, SwissBorg was looking to strengthen its Earn offering by sourcing state-of-the-art yield solutions that combine steady performance, proven reliability, and uncompromising security. While Enzyme provides the infrastructure for projects to build and operate their own on-chain financial products, it also plays an active role in helping those products scale. Through our distribution service, we identified Stader Labs’ ETHx Hyperloop as an ideal fit for SwissBorg’s offering, and facilitated its integration directly into the SwissBorg interface.

Leveraging Enzyme’s white-label capabilities and industry-leading security architecture, the Hyperloop integration was completed quickly and seamlessly—empowering SwissBorg users to access a risk-managed, yield-generating strategy without sacrificing security or user experience.

‍

The result

SwissBorg users can now seamlessly access Stader Labs’ Hyperloop strategy. For SwissBorg, this distribution partnership has enabled the platform to expand its yield offering and deliver new investment opportunities to its users—with minimal effort.

For Stader Labs, tapping into Enzyme’s strong network of distributors and exchanges has opened new distribution channels and accelerated the adoption of its product which reached max Cap on Swissborg. Enzyme continues to support day-to-day operations, acting as a bridge between project teams and the underlying DeFi protocols to ensure smooth execution and scalability. For example, Enzyme coordinated efforts to increase the supply cap on Aave, enabling more depositors to participate in the strategy.

‍